[Depression in HIV infection: prevalence, risk factors and management].
Depression is one of the main psychiatric co-morbidities in HIV infection, presenting with a significantly higher prevalence than in the general population (around 35%). Its presence has been associated with poor quality of life, HIV disease progression and poor adherence to antiretroviral therapy. Although antidepressive treatment has demonstrated effectiveness on the management of depressive symptoms, improvement of clinical and laboratory parameters, and enhancement of antiretroviral adherence, depression is frequently under diagnosed and under treated in these patients. We analyzed the main international findings on depression prevalence, risk factors, con-sequences and management in people with HIV disease.
Escuela de Salud Pública, Universidad de Chile, Santiago, Chile. clausiwola@msn.com
Claudia
C
Wolff L
Rubén
R
Alvarado M
Marcelo
M
Wolff R
D000928:Antidepressive Agents / Q000627:therapeutic use; D003863:Depression / Q000209:etiology* / Q000628:therapy; D039721:Diagnostic and Statistical Manual of Mental Disorders; D015658:HIV Infections / Q000523:psychology*; D006801:Humans; D015995:Prevalence; D011613:Psychotherapy; D012307:Risk Factors
D000928:Antidepressive Agents